Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALT

Altimmune Inc

May 12 • 12:04PM ET

3.03

-0.06 -1.90 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: VKTX GPCR XERS INO NVAX

| Held by: XBI VTI IWM VXF IWO IBB VTWO FESM IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.02	Insider Own	8.31%	Shs Outstand	194.35M	Perf Week	-0.94%
Market Cap	589.15M	Forward P/E	-	EPS next Y	-1.16	Insider Trans	0.56%	Shs Float	178.21M	Perf Month	-6.15%
Enterprise Value	351.34M	PEG	-	EPS next Q	-0.24	Inst Own	51.32%	Short Float	19.89%	Perf Quarter	-34.81%
Income	-88.09M	P/S	14728.78	EPS this Y	-6.80%	Inst Trans	20.60%	Short Ratio	8.83	Perf Half Y	-26.25%
Sales	0.04M	P/B	1.49	EPS next Y	-8.67%	ROA	-42.03%	Short Interest	35.45M	Perf YTD	-16.03%
Book/sh	2.03	P/C	2.15	EPS next 5Y	14.23%	ROE	-50.57%	52W High	7.73 -60.79%	Perf Year	-49.56%
Cash/sh	1.41	P/FCF	-	EPS past 3/5Y	17.87% 12.17%	ROIC	-33.84%	52W Low	2.56 18.41%	Perf 3Y	-40.45%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -65.33%	Gross Margin	-173.17%	Volatility	5.79% 5.81%	Perf 5Y	-76.41%
Dividend TTM	-	EV/Sales	8783.53	EPS Y/Y TTM	24.14%	Oper. Margin	-230460.98%	ATR (14)	0.19	Perf 10Y	-96.17%
Dividend Ex-Date	-	Quick Ratio	18.54	Sales Y/Y TTM	105.00%	Profit Margin	-214860.98%	RSI (14)	46.14	Recom	1.45
Dividend Gr. 3/5Y	- -	Current Ratio	18.54	EPS Q/Q	16.42%	SMA20	-1.85%	Beta	0.19	Target Price	18.15
Payout	-	Debt/Eq	0.16	Sales Q/Q	420.00%	SMA50	-8.18%	Rel Volume	0.58	Prev Close	3.09
Employees	57	LT Debt/Eq	0.16	Earnings	May 13 BMO	SMA200	-24.11%	Avg Volume	4.01M	Price	3.03
IPO	Oct 06, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.38% 4233.33%	Trades		Volume	985,409	Change	-1.90%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)